I'm LongbridgeAI, I can summarize articles.City Therapeutics (CTY.US) fell more than 6% during regular trading to $19.37, hitting a 52-week low.
The stock is up 18.75% from its IPO price.
The Nasdaq Composite is down 2.13% over the past five sessions and up 10.19% year to date.
Based on public media reports. AI-generated; not investment advice.
